Neurogene Announces First Patient Dosed in High-Dose Cohort of Ngn-401 Gene Therapy Clinical Trial for Rett Syndrome
Neurogene宣佈Rett綜合症Ngn-401基因療法臨床試驗高劑量組首位患者接受治療
Neurogene Announces First Patient Dosed in High-Dose Cohort of Ngn-401 Gene Therapy Clinical Trial for Rett Syndrome
Neurogene宣佈Rett綜合症Ngn-401基因療法臨床試驗高劑量組首位患者接受治療
譯文內容由第三人軟體翻譯。